Lisa J Shah, PA | UniHealth

Offices

1 location · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Lisa J Shah’s office at (650) 723-4000 to ask if they take your plan before you enroll.

California Medical Board record

Licence C54260 · Current

Licensed to practise in California · since 2010 · expires 2028-04-30 · University of Pittsburgh School of Medicine.

Matched on the licence number without its letter prefix; check the name before relying on it.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024

See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Sort by

Every scored measure at Stanford Health Care

Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths	5.31 (4.24 to 6.37) · 8,661 cases	Worse	Jul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits	14.1 (12.7 to 15.7) · 2,191 cases	Worse	Jan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths	4.08 (1.95 to 6.21) · 5,296 cases	Better	Jul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections	0.317	Better	Oct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections	0.446	Better	Oct 2024 – Sep 2025
SSI - Colon SurgeryInfections	0.241	Better	Oct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits	0.7 (0.6 to 0.9) · 3,348 cases	Better	Jan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths	1.06 (0.45 to 1.67) · 5,374 cases	No different	Jul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths	0.86 (0.72 to 1)	No different	Jul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths	166.09 (137.88 to 194.3) · 470 cases	No different	Jul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths	1.1 · 192 cases	None	Jul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths	6.4 · 146 cases	None	Jul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths	9.7 · 253 cases	None	Jul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths	6.3 · 880 cases	None	Jul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths	10.3 · 935 cases	None	Jul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths	8.7 · 501 cases	None	Jul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths	2.1 · 7,730 cases	None	Jul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths	0.13 (0 to 0.27) · 20,799 cases	No different	Jul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths	0.28 (0.14 to 0.43) · 23,182 cases	No different	Jul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths	0.94 (0.2 to 1.68) · 5,694 cases	No different	Jul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths	2.36 (1.54 to 3.19) · 7,846 cases	No different	Jul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths	5.2 (3.76 to 6.64) · 5,603 cases	No different	Jul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths	1.38 (0.23 to 2.53) · 2,211 cases	No different	Jul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths	0.52 (0.21 to 0.83) · 19,915 cases	No different	Jul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths	3.6 · 416 cases	None	Apr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections	0.869	No different	Oct 2024 – Sep 2025
MRSA BacteremiaInfections	0.857	No different	Oct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections	0.368	No different	Oct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits	16.2 · 247 cases	None	Jul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits	20.5 · 1,021 cases	None	Jul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits	47.8 · 258 cases	None	Jul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits	-1.6 · 990 cases	None	Jul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits	20.8 · 976 cases	None	Jul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits	16.5 · 959 cases	None	Jul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits	5.2 (4.4 to 6.2) · 2,191 cases	No different	Jan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits	5.1 · 425 cases	None	Jul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits	9.6 · 158 cases	None	Jul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits	19.6 · 183 cases	None	Jul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits	12.7 (10.4 to 15.4) · 4,578 cases	No different	Jan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Sort by

Patient survey stars by topic at Stanford Health Care

Cleanliness	4
Nurse communication	4
Doctor communication	4
Communication about medicines	3
Discharge information	4
Overall hospital rating	4
Quietness	2
Recommend hospital	5

Sort by

Share of patients giving the best answer at Stanford Health Care

Room was "always" clean	75%
Nurses "always" communicated well	82%
Doctors "always" communicated well	81%
Staff "always" explained	63%
Yes, staff "did" give patients this information	89%
Yes, staff "did" give patients information about help after discharge	89%
Doctors "always" explained things so they could understand	76%
Doctors "always" listened carefully	80%
Doctors "always" treated them with courtesy and respect	87%
Patients who gave a rating of "9" or "10" (high)	79%
Staff "always" explained new medications	76%
Nurses "always" explained things so they could understand	77%
Nurses "always" listened carefully	79%
Nurses "always" treated them with courtesy and respect	88%
"Always" quiet at night	53%
"YES", patients would definitely recommend the hospital	83%
Staff "always" explained possible side effects	50%
Yes, staff "did" give patients information about possible symptoms	90%

Original Medicare doctor bills

$17,979

Medicare paid this office $17,979 for 142 people. Most of that is long return visits and Botox.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Sort by

Largest Original Medicare bills

Long return visit (40+ min)	23	$4,623	$132
Long return visit (40+ min)	43	$4,433	$90
Return visit (30+ min)	67	$4,045	$56
Return visit (30+ min)	33	$3,976	$95

Who their Medicare patients are

142 Original Medicare patients in 2024. Average age 73 · Also on Medicaid 19% · Health risk score 1.41. Above the middle of the specialty; the typical physician assistant clinician is at 1.31.

Conditions among them: Cancer 75% · High blood pressure 55% · Diabetes 25% · Chronic kidney disease 16% · Depression 16% · COPD 8% · Atrial fibrillation 8%.

The office billed $86,974, Medicare allowed $26,823 and paid $17,979; for 215 services of 5 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Sort by

Original Medicare by year

2024	142	215	73	1.41	$86,974	$17,979
2023	156	270	73	1.29	$90,934	$22,837
2022	141	207	72	1.23	$64,649	$16,404
2021	102	128	72	1.14	$45,104	$12,302
2020	77	94	71	1.18	$26,968	$5,518
2019	58	66	70	1.26	$6,104	$3,714
2016	429	918	72	2.11	$239,185	$35,277
2015	512	1,306	72	1.92	$298,128	$44,774
2014	434	979	72	1.87	$218,766	$32,116
2013	404	814	72	1.71	$185,318	$28,811

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 3 services

Sort by

Original Medicare services billed in 2023

Long return visit (40+ min)	69	$12,655	$107
Return visit (30+ min)	102	$8,981	$71
Short return visit (20+ min)	12	$527	$41

2022: 3 services

Sort by

Original Medicare services billed in 2022

Long return visit (40+ min)	53	$7,251	$101
Return visit (30+ min)	89	$7,048	$69
Short return visit (20+ min)	20	$1,045	$47

2021: 2 services

Sort by

Original Medicare services billed in 2021

Long return visit (40+ min)	64	$8,705	$110
Return visit (30+ min)	33	$2,295	$66

2020: 2 services

Sort by

Original Medicare services billed in 2020

Return visit (30+ min)	53	$2,636	$44
Long return visit (40+ min)	22	$2,223	$85

2019: 1 service

Sort by

Original Medicare services billed in 2019

Return visit (30+ min)	47	$3,006	$58

2016: 2 services

Sort by

Original Medicare services billed in 2016

Return visit (30+ min)	220	$21,102	$49
Short return visit (20+ min)	309	$14,054	$29

2015: 3 services

Sort by

Original Medicare services billed in 2015

Short return visit (20+ min)	478	$33,730	$31
Return visit (30+ min)	138	$10,803	$51
Short return visit	15	$241	$16

2014: 2 services

Sort by

Original Medicare services billed in 2014

Short return visit (20+ min)	411	$27,311	$32
Return visit (30+ min)	80	$4,619	$43

2013: 2 services

Sort by

Original Medicare services billed in 2013

Short return visit (20+ min)	350	$22,499	$33
Return visit (30+ min)	100	$6,196	$50

Drugs they prescribed that Part D paid

$817,806

Pharmacies billed $817,806 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

281 generic and 57 brand-name prescriptions · $817,806 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Sort by

Largest Part D drug costs

Ibrance	16	$249,282	$15,580
Verzenio	11	$170,680	$15,516
Exemestane	40	$9,069	$227
Anastrozole	104	$2,408	$23
Tamoxifen Citrate	31	$468	$15

See all 8 drugs

Sort by

Every Part D drug this clinician prescribed

Ibrance	16	$249,282	$15,580
Verzenio	11	$170,680	$15,516
Exemestane	40	$9,069	$227
Anastrozole	104	$2,408	$23
Tamoxifen Citrate	31	$468	$15
Letrozole	22	$312	$14
Alendronate	13	$158	$12
Gabapentin	11	$138	$13

Year by year

Sort by

Part D prescribing by year

2024	338	99	None	17%	$817,806
2023	328	102	None	16%	$600,395
2022	402	108	3% (11)	17%	$900,539
2021	479	118	None	15%	$823,807
2020	356	97	5% (16)	19%	$617,848
2019	161	63	None	16%	$218,403
2018	18	14	None	None	$50,712
2017	31	15	None	None	$1,476
2016	844	276	0% (0)	13%	$121,194
2015	1,088	335	None	None	$96,755
2014	759	253	2% (16)	None	$111,223
2013	607	206	4% (24)	15%	$38,738

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 6 drugs

Sort by

Part D drugs prescribed in 2023

Exemestane	40	$9,485	$237
Anastrozole	105	$3,415	$33
Tamoxifen Citrate	35	$1,285	$37
Letrozole	18	$256	$14
Gabapentin	16	$177	$11
Ondansetron	14	$101	$7

2022: 9 drugs

Sort by

Part D drugs prescribed in 2022

Ibrance	29	$430,644	$14,850
Verzenio	15	$209,807	$13,987
Exemestane	41	$14,201	$346
Anastrozole	123	$2,962	$24
Tamoxifen Citrate	35	$1,483	$42
Letrozole	31	$866	$28
Alendronate	11	$151	$14
Ondansetron	12	$99	$8
Lorazepam	12	$46	$4

2021: 10 drugs

Sort by

Part D drugs prescribed in 2021

Ibrance	30	$424,713	$14,157
Verzenio	16	$224,359	$14,022
Exemestane	40	$11,175	$279
Anastrozole	157	$4,393	$28
Tamoxifen Citrate	29	$1,650	$57
Letrozole	32	$1,365	$43
Ondansetron	19	$592	$31
Gabapentin	19	$325	$17
Alendronate	11	$118	$11
Lorazepam	15	$56	$4

2020: 7 drugs

Sort by

Part D drugs prescribed in 2020

Ibrance	29	$383,728	$13,232
Lynparza	12	$88,081	$7,340
Exemestane	15	$7,755	$517
Tamoxifen Citrate	39	$2,415	$62
Anastrozole	78	$2,110	$27
Letrozole	33	$883	$27
Gabapentin	14	$116	$8

2019: 3 drugs

Sort by

Part D drugs prescribed in 2019

Exemestane	18	$9,183	$510
Anastrozole	29	$725	$25
Letrozole	19	$260	$14

2016: 23 drugs

Sort by

Part D drugs prescribed in 2016

Xarelto	18	$8,848	$492
Enoxaparin	12	$8,313	$693
Cholestyramine	21	$1,140	$54
Megestrol Acetate	14	$1,051	$75
Tamoxifen Citrate	30	$1,022	$34
Anastrozole	56	$986	$18
Bumetanide	23	$830	$36
Hydroxyurea	20	$671	$34
Potassium Chloride	29	$577	$20
Levofloxacin	27	$384	$14
Prednisone	66	$318	$5
Methylprednisolone	18	$291	$16
Letrozole	18	$262	$15
Ondansetron	17	$259	$15
Warfarin	36	$232	$6
Klor-Con M10	11	$215	$20
Omeprazole	26	$190	$7
Gabapentin	15	$95	$6
Amoxicillin	31	$92	$3
Promethazine	14	$88	$6
Ciprofloxacin	13	$81	$6
Lisinopril	15	$45	$3
Amlodipine Besylate	11	$30	$3

2015: 31 drugs

Sort by

Part D drugs prescribed in 2015

Xarelto	14	$5,970	$426
Megestrol Acetate	25	$1,207	$48
Cholestyramine	21	$1,138	$54
Tamoxifen Citrate	39	$1,094	$28
Hydroxyurea	28	$954	$34
Levofloxacin	48	$668	$14
Anastrozole	43	$662	$15
Gabapentin	44	$651	$15
Ondansetron	25	$593	$24
Prednisone	92	$518	$6
Methylprednisolone	27	$512	$19
Warfarin	55	$424	$8
Lidocaine-Prilocaine	14	$418	$30
Bumetanide	17	$391	$23
Triamcinolone Acetonide	21	$381	$18
Klor-Con M10	18	$361	$20
Potassium Chloride	18	$340	$19
Fluconazole	12	$279	$23
Tamsulosin	19	$262	$14
Bicalutamide	14	$261	$19
Amoxicillin-Clavulanate Potass	12	$227	$19
Letrozole	12	$202	$17
Ciprofloxacin	20	$188	$9
Promethazine	19	$171	$9
Levothyroxine	15	$165	$11
Dicyclomine	22	$153	$7
Azithromycin	22	$134	$6
Omeprazole	14	$128	$9
Amoxicillin	24	$83	$3
Cephalexin	18	$66	$4
Furosemide	11	$51	$5

2014: 23 drugs

Sort by

Part D drugs prescribed in 2014

Anastrozole	39	$1,293	$33
Megestrol Acetate	26	$1,231	$47
Tamoxifen Citrate	48	$1,044	$22
Hydroxyurea	29	$1,035	$36
Levofloxacin	47	$775	$16
Nifedipine Er	13	$516	$40
Ondansetron	21	$399	$19
Lidocaine-Prilocaine	13	$376	$29
Methylprednisolone	18	$375	$21
Fluconazole	15	$368	$25
Triamcinolone Acetonide	17	$353	$21
Warfarin	37	$321	$9
Potassium Chloride	14	$311	$22
Klor-Con M10	15	$307	$20
Prednisone	41	$244	$6
Dexamethasone	12	$231	$19
Azithromycin	18	$156	$9
Omeprazole	12	$115	$10
Ciprofloxacin	20	$105	$5
Promethazine	11	$87	$8
Tramadol	16	$74	$5
Furosemide	16	$56	$4
Amoxicillin	12	$35	$3

2013: 16 drugs

Sort by

Part D drugs prescribed in 2013

Megestrol Acetate	17	$988	$58
Anastrozole	32	$985	$31
Hydroxyurea	19	$565	$30
Tamoxifen Citrate	24	$526	$22
Methylprednisolone	22	$483	$22
Warfarin	38	$321	$8
Azithromycin	32	$305	$10
Ondansetron	11	$286	$26
Levofloxacin	25	$264	$11
Letrozole	12	$260	$22
Tramadol	21	$110	$5
Prednisone	27	$95	$4
Cephalexin	12	$83	$7
Furosemide	15	$79	$5
Omeprazole	11	$76	$7
Ciprofloxacin	11	$60	$5

Money from drug and device companies

$283 in 2023

Sort by

Industry payments by year

2023	3	4	None	$283
2022	2	6	None	$450

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Sort by

Payments by company

Stemline Therapeutics	Orserdu	$180	2 payments Meals for Orserdu · 2023-03-16 · $120 Meals for Orserdu · 2023-02-07 · $60
Seagen	None	$79	1 payment Education · 2023-01-26 · $79
AstraZeneca Pharmaceuticals LP	Enhertu	$24	1 payment Meals for Enhertu · 2023-04-20 · $24

See all 4 published payments

Sort by

Every published payment

AstraZeneca Pharmaceuticals LP	Meals · 2023-04-20	Enhertu	$24
Stemline Therapeutics	Meals · 2023-03-16	Orserdu	$120
Stemline Therapeutics	Meals · 2023-02-07	Orserdu	$60
Seagen	Education · 2023-01-26	None	$79

See earlier years (2022)

2022: $450

Sort by

Payments by company in 2022

AstraZeneca Pharmaceuticals LP	Enhertu	$272	4 payments Meals for Enhertu · 2022-09-21 · $124 Meals for Enhertu · 2022-09-07 · $3 Meals for Enhertu · 2022-09-07 · $21 Meals for Enhertu · 2022-07-27 · $123
Tactile Systems Technology	Flexitouch Plus	$179	2 payments Meals for Flexitouch Plus · 2022-10-20 · $139 Education for Flexitouch Plus · 2022-10-20 · $40

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score: 76.5 / 100; Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI: 1326318510
Licence: CA 54260California C54260: Current · expires 2028-04-30
Trained: Medical College of Georgia School of Medicine, 2011 · 15 years ago
Group: Stanford Health Care
Video visits: Lists video visits
Gender: Female

More record details

Sole proprietor: No
Taxonomy: Physician assistant (363A00000X); Physician assistant, medical (363AM0700X)
Mailing address: 300 Pasteur Dr, Stanford, CA, 94305
NPI first listed: 2012-01-05
NPI last updated: 2025-12-18
NPI record certified: 2025-12-18

This is when the NPI record was last certified, not a medical board exam.